Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
27.60M | 22.77M | 19.09M | 8.39M | 4.12M | Gross Profit |
4.89M | 2.14M | 2.34M | 2.77M | 2.65M | EBIT |
-609.00K | -7.01M | -5.94M | -1.03M | 188.04K | EBITDA |
-331.00K | -1.24M | -2.28M | 1.02M | 697.11K | Net Income Common Stockholders |
-5.11M | -6.91M | -4.45M | -383.62K | 382.90K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.04M | 8.81M | 6.35M | 14.12M | 4.20M | Total Assets |
59.65M | 62.53M | 63.91M | 47.05M | 32.22M | Total Debt |
1.66M | 755.00K | 1.12M | 799.36K | 44.27K | Net Debt |
-3.38M | -8.05M | -5.23M | -13.32M | -4.16M | Total Liabilities |
12.52M | 15.31M | 15.33M | 4.96M | 3.01M | Stockholders Equity |
47.14M | 47.22M | 48.58M | 42.09M | 29.22M |
Cash Flow | Free Cash Flow | |||
-4.51M | -1.88M | -4.83M | -2.64M | -26.13K | Operating Cash Flow |
-492.00K | 768.00K | -2.32M | 240.65K | 1.05M | Investing Cash Flow |
-4.02M | -2.65M | -5.16M | -2.98M | -849.49K | Financing Cash Flow |
749.00K | 4.34M | -286.00K | 12.65M | -128.49K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | AU$54.61B | 27.14 | 25.23% | 0.85% | 10.54% | 38.69% | |
64 Neutral | AU$16.55M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
56 Neutral | AU$72.45M | ― | -11.80% | ― | 14.56% | 13.36% | |
52 Neutral | $5.23B | 3.70 | -41.86% | 2.84% | 16.58% | -0.16% | |
50 Neutral | AU$769.90M | ― | -112.97% | ― | ― | -84.82% | |
48 Neutral | AU$321.45M | ― | -0.87% | 6.18% | 14.24% | -109.59% |
Beamtree Holdings Limited has announced significant progress in its operations for the third quarter of FY25, highlighted by major contract wins and strategic developments. The company has launched the Evolve Collaborative with NHS Confederation in England, renewed a contract in Ireland, and expanded its market presence in Saudi Arabia and the UK. These developments are expected to significantly increase Beamtree’s market share and annual recurring revenue, positioning the company for improved profitability and positive cash generation by the end of FY25.
Beamtree Holdings Limited has announced strategic contract wins for its autonomous coding technology with Barwon Health in Australia, Milton Keynes University NHS Foundation Trust in the UK, and a leading health sciences medical center in Canada. These contracts, while not financially material, signify a strategic milestone for Beamtree, showcasing the demand for its AI technology in key markets and marking the conversion of its sales pipeline as outlined in their first-half reporting.
Beamtree Holdings Limited has secured three new contracts in Australia, the UK, and Canada for its autonomous coding product, valued at approximately $0.6 million annually. These contracts highlight the demand for Beamtree’s AI technology in key markets and mark a strategic achievement that supports the company’s growth and innovation in healthcare data solutions.
Beamtree Holdings Limited has announced the appointment of Professor Andy Hardy to its board of directors, effective 31 March 2025. Professor Hardy, a prominent figure in the healthcare sector, is expected to enhance Beamtree’s strategic direction with his extensive experience in health service leadership and innovation in AI. Concurrently, Professor Mark Britnell will step down from the board to focus on his UK commitments, having significantly contributed to Beamtree’s international success and the development of the Global Impact Committee.
Beamtree Holdings Limited has released its 1H FY25 results, providing a general background on the company’s performance. The release emphasizes that the information is for professional analysts and should not be relied upon as investment advice. The company warns against placing undue reliance on forward-looking statements and clarifies that the past performance is illustrative only. The announcement highlights the importance of understanding that many factors, including risks and uncertainties, could cause actual results to differ from those projected.
Beamtree Holdings Limited announced continued double-digit revenue growth of 10% for the first half of fiscal year 2025, driven by a 31% increase in international revenue and a high customer renewal rate. The company reported an operating profit, breaking even in cash flow, and securing a new NZ$7.5 million debt facility to support its growth plans. Significant developments include the launch of an Integrated Coding Platform in Saudi Arabia, verbal agreements for new implementations in several countries, and a strong sales pipeline of $61 million. These efforts are expected to accelerate revenue growth and position the company for a cash flow positive status by the end of fiscal year 2025, with a forecast ARR growth target of 20% year on year.
Beamtree Holdings Limited reported a 10% increase in revenue from ordinary activities, reaching $14,235,000 for the year ended December 31, 2024. Despite the growth in revenue, the company experienced a 12% increase in losses attributable to owners, amounting to $3,246,000, influenced by rising employment costs and other operating expenses.